New Enterprise Associates 17, L.P.'s Net Worth
$319 Million
Who is New Enterprise Associates 17, L.P.?
New Enterprise Associates 17, L.P. has an estimated net worth of $319 Million. This is based on reported shares across multiple companies, which include Robinhood Markets, Inc., Monte Rosa Therapeutics, Inc., Savara Inc, Bright Health Group Inc., and Korro Bio, Inc..
SEC CIK
New Enterprise Associates 17, L.P.'s CIK is 0001768564
Past Insider Trading and Trends
2021 was New Enterprise Associates 17, L.P.'s most active year for acquiring shares with 18 total transactions. New Enterprise Associates 17, L.P.'s most active month to acquire stocks was the month of July. 2021 was New Enterprise Associates 17, L.P.'s most active year for disposing of shares, totalling 17 transactions. New Enterprise Associates 17, L.P.'s most active month to dispose stocks was the month of July. 2021 saw New Enterprise Associates 17, L.P. paying a total of $97,068,720.00 for 151,063,318 shares, this is the most they've acquired in one year. In 2021 New Enterprise Associates 17, L.P. cashed out on 169,677,369 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Robinhood Markets, Inc. (HOOD) Snapshot price: $11.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -50.00% | -23.82M |
—
|
—
| 23.82M |
May 2
| |||
Form 4
| -33.37% | -23.87M |
—
|
—
| 47.65M |
Jan 28
| |||
Form 4
| -1.96% | -1.43M |
—
|
—
| 71.51M |
Nov 10
| |||
Form 4
| -1.92% | -1.43M |
—
|
—
| 72.94M |
Oct 27
| |||
Form 4
| +2,863.90% | 71.86M |
$26.60 |
—
| 74.37M |
Aug 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Monte Rosa Therapeutics, Inc. (GLUE) Snapshot price: $5.07
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 7.69M |
$19.00 |
—
| 7.69M |
Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Savara Inc (SVRA) Snapshot price: $4.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.38% | 333.33K |
$3.00 | $999,999.00 | 24.47M |
Jul 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NeueHealth, Inc. (BHG) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Korro Bio, Inc. (KRRO) Snapshot price: $60.255
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.66% | 17.86K |
$56.00 | $999,992.00 | 1.09M |
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||